The Enterprise Value as of December 2025 (TTM) for Kairos Pharma, Ltd. (KAPA) is 13.29M

According to Kairos Pharma, Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.29M. This represents a change of -8.50% compared to the average of 14.52M of the last 4 quarters.

Kairos Pharma, Ltd. (KAPA) Historical Enterprise Value (quarterly & annually)

How has KAPA Enterprise Value performed in the past?

The mean historical Enterprise Value of Kairos Pharma, Ltd. over the last ten years is 26.64M. The current 13.29M Enterprise Value has changed 4.89% with respect to the historical average. Over the past ten years (40 quarters), KAPA's Enterprise Value was at its highest in in the June 2024 quarter at 34.15M. The Enterprise Value was at its lowest in in the March 2022 quarter at 0.

Kairos Pharma, Ltd. (KAPA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kairos Pharma, Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kairos Pharma, Ltd. (KAPA) Average Enterprise Value

How has KAPA Enterprise Value performed in the past?

The current Enterprise Value of Kairos Pharma, Ltd. (KAPA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kairos Pharma, Ltd. (KAPA) Enterprise Value vs. Peers

How is KAPA’s Enterprise Value compared to its peers?

Kairos Pharma, Ltd.’s Enterprise Value is less than Lixte Biotechnology Holdings, Inc. (18.45M), greater than Pelthos Therapeutics Inc. (6.32M), less than Lexaria Bioscience Corp. (15.80M), less than CASI Pharmaceuticals, Inc. (29.33M), greater than Allarity Therapeutics, Inc. (-47067.00), greater than Clearside Biomedical, Inc. (-3870682.00), greater than Cingulate Inc. (-4702578210.00), greater than BriaCell Therapeutics Corp. (10.69M), greater than Entero Therapeutics, Inc. (9.37M), greater than Pulmatrix, Inc. (10.80M),

Build a custom stock screener for Kairos Pharma, Ltd. (KAPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kairos Pharma, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kairos Pharma, Ltd. (KAPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kairos Pharma, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.